134 related articles for article (PubMed ID: 12941383)
1. Interleukin-4-mediated downregulation of cytotoxic T lymphocyte activity is associated with reduced proliferation of antigen-specific CD8+ T cells.
Rolph MS; Ramshaw IA
Microbes Infect; 2003 Sep; 5(11):923-32. PubMed ID: 12941383
[TBL] [Abstract][Full Text] [Related]
2. Loss of antiviral cytotoxic T-lymphocyte activity during high-level antigen stimulation.
Rolph MS; Matthaei KI; Carbone FR; Heath WR; Ramshaw IA
Viral Immunol; 1998; 11(4):183-95. PubMed ID: 10189186
[TBL] [Abstract][Full Text] [Related]
3. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses.
Xiao Z; Curtsinger JM; Prlic M; Jameson SC; Mescher MF
Int Immunol; 2007 Jun; 19(6):733-43. PubMed ID: 17545279
[TBL] [Abstract][Full Text] [Related]
4. Antigen is required for the activation of effector activities, whereas interleukin 2 Is required for the maintenance of memory in ovalbumin-specific, CD8+ cytotoxic T lymphocytes.
Ke Y; Ma H; Kapp JA
J Exp Med; 1998 Jan; 187(1):49-57. PubMed ID: 9419210
[TBL] [Abstract][Full Text] [Related]
5. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
Kezuka T; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
[TBL] [Abstract][Full Text] [Related]
6. Injection of soluble antigen into the anterior chamber of the eye induces expansion and functional unresponsiveness of antigen-specific CD8+ T cells.
McKenna KC; Xu Y; Kapp JA
J Immunol; 2002 Nov; 169(10):5630-7. PubMed ID: 12421942
[TBL] [Abstract][Full Text] [Related]
7. CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation.
Thomas MJ; Noble A; Sawicka E; Askenase PW; Kemeny DM
J Immunol; 2002 Jan; 168(1):216-23. PubMed ID: 11751965
[TBL] [Abstract][Full Text] [Related]
8. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
[TBL] [Abstract][Full Text] [Related]
9. In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen).
Goldberg J; Shrikant P; Mescher MF
J Immunol; 2003 Jan; 170(1):228-35. PubMed ID: 12496404
[TBL] [Abstract][Full Text] [Related]
10. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
11. Antigen delivery by alpha(2)-macroglobulin enhances the cytotoxic T lymphocyte response.
Bowers EV; Horvath JJ; Bond JE; Cianciolo GJ; Pizzo SV
J Leukoc Biol; 2009 Nov; 86(5):1259-68. PubMed ID: 19652028
[TBL] [Abstract][Full Text] [Related]
12. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes.
Love VA; Grabie N; Duramad P; Stavrakis G; Sharpe A; Lichtman A
Circ Res; 2007 Aug; 101(3):248-57. PubMed ID: 17569889
[TBL] [Abstract][Full Text] [Related]
13. Adoptively transferred late allergic airway responses are associated with Th2-type cytokines in the rat.
Watanabe A; Mishima H; Kotsimbos TC; Hojo M; Renzi PM; Martin JG; Hamid QA
Am J Respir Cell Mol Biol; 1997 Jan; 16(1):69-74. PubMed ID: 8998081
[TBL] [Abstract][Full Text] [Related]
14. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
[TBL] [Abstract][Full Text] [Related]
16. Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells.
Goding SR; Yu S; Bailey LM; Lotze MT; Basse PH
Clin Immunol; 2017 Apr; 177():76-86. PubMed ID: 27377534
[TBL] [Abstract][Full Text] [Related]
17. Mannosylated mucin-type immunoglobulin fusion proteins enhance antigen-specific antibody and T lymphocyte responses.
Ahlén G; Strindelius L; Johansson T; Nilsson A; Chatzissavidou N; Sjöblom M; Rova U; Holgersson J
PLoS One; 2012; 7(10):e46959. PubMed ID: 23071675
[TBL] [Abstract][Full Text] [Related]
18. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
Krishnan L; Sad S; Patel GB; Sprott GD
J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
[TBL] [Abstract][Full Text] [Related]
19. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
[TBL] [Abstract][Full Text] [Related]
20. Antigen-specific CD8+ T cells inhibit IgE responses and interleukin-4 production by CD4+ T cells.
Holmes BJ; MacAry PA; Noble A; Kemeny DM
Eur J Immunol; 1997 Oct; 27(10):2657-65. PubMed ID: 9368623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
